[{"address1": "126 East Lincoln Avenue", "city": "Rahway", "state": "NJ", "zip": "07065", "country": "United States", "phone": "908 740 4000", "website": "https://www.merck.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and anti-PD-1 therapy, as well as KEYTRUDA (pembrolizumab) in patients with advanced solid tumors. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.", "fullTimeEmployees": 73000, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert M. Davis J.D.", "age": 57, "title": "Chairman, President & CEO", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 4946636, "exercisedValue": 12137946, "unexercisedValue": 8920883}, {"maxAge": 1, "name": "Ms. Caroline A. Litchfield", "age": 55, "title": "Executive VP & CFO", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 2647054, "exercisedValue": 2581579, "unexercisedValue": 7022207}, {"maxAge": 1, "name": "Ms. Betty D. Larson", "age": 48, "title": "Executive VP & Chief Human Resources Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 2294965, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard R. DeLuca Jr.", "age": 61, "title": "Executive VP & President of Merck Animal Health", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 2169938, "exercisedValue": 0, "unexercisedValue": 5823540}, {"maxAge": 1, "name": "Dr. Dean Y. Li M.D., Ph.D.", "age": 61, "title": "Executive VP & President of Merck Research Laboratories", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 3281100, "exercisedValue": 932530, "unexercisedValue": 4699987}, {"maxAge": 1, "name": "Mr. Dalton E. Smart III", "age": 57, "title": "Senior VP of Finance, Principal Accounting Officer & Global Controller", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David Michael Williams", "age": 55, "title": "Executive VP and Chief Information & Digital Officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter  Dannenbaum", "title": "Vice President of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer L. Zachary J.D.", "age": 46, "title": "Executive VP & General Counsel", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 2732334, "exercisedValue": 3461623, "unexercisedValue": 4142191}, {"maxAge": 1, "name": "Ms. Cristal N. Downing", "age": 55, "title": "Executive VP and Chief Communications & Public Affairs Officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 5, "compensationRisk": 4, "shareHolderRightsRisk": 2, "overallRisk": 3, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.merck.com/investors/home.html", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 94.97, "open": 95.48, "dayLow": 95.36, "dayHigh": 100.27, "regularMarketPreviousClose": 94.97, "regularMarketOpen": 95.48, "regularMarketDayLow": 95.36, "regularMarketDayHigh": 100.27, "dividendRate": 3.4, "dividendYield": 3.48, "exDividendDate": 1765756800, "payoutRatio": 0.4286, "fiveYearAvgDividendYield": 3.05, "beta": 0.319, "trailingPE": 12.931217, "forwardPE": 10.400001, "volume": 23150040, "regularMarketVolume": 23150040, "averageVolume": 12592573, "averageVolume10days": 15160170, "averageDailyVolume10Day": 15160170, "bid": 98.03, "ask": 98.15, "bidSize": 300, "askSize": 200, "marketCap": 244183302144, "fiftyTwoWeekLow": 73.31, "fiftyTwoWeekHigh": 105.07, "allTimeHigh": 134.63, "allTimeLow": 0.265055, "priceToSalesTrailing12Months": 3.801406, "fiftyDayAverage": 86.067, "twoHundredDayAverage": 84.0197, "trailingAnnualDividendRate": 3.2, "trailingAnnualDividendYield": 0.033694852, "currency": "USD", "tradeable": false, "enterpriseValue": 265859530752, "profitMargins": 0.29632, "floatShares": 2478026480, "sharesOutstanding": 2482022536, "sharesShort": 25815354, "sharesShortPriorMonth": 25174694, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.0104, "heldPercentInsiders": 0.00058, "heldPercentInstitutions": 0.80284, "shortRatio": 2.18, "shortPercentOfFloat": 0.0116, "impliedSharesOutstanding": 2497783212, "bookValue": 20.845, "priceToBook": 4.689854, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "earningsQuarterlyGrowth": 0.832, "netIncomeToCommon": 19033999360, "trailingEps": 7.56, "forwardEps": 9.4, "lastSplitFactor": "1048:1000", "lastSplitDate": 1622678400, "enterpriseToRevenue": 4.139, "enterpriseToEbitda": 8.434, "52WeekChange": -0.061190188, "SandP52WeekChange": 0.09209216, "lastDividendValue": 0.81, "lastDividendDate": 1757894400, "quoteType": "EQUITY", "currentPrice": 97.76, "targetHighPrice": 139.0, "targetLowPrice": 82.0, "targetMeanPrice": 102.92423, "targetMedianPrice": 100.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 26, "totalCash": 18214000640, "totalCashPerShare": 7.338, "ebitda": 31523000320, "totalDebt": 41373999104, "quickRatio": 1.09, "currentRatio": 1.661, "totalRevenue": 64234999808, "debtToEquity": 79.708, "revenuePerShare": 25.559, "returnOnAssets": 0.13755, "returnOnEquity": 0.39485002, "grossProfits": 50007998464, "freeCashflow": 14527875072, "operatingCashflow": 17064999936, "earningsGrowth": 0.87, "revenueGrowth": 0.037, "grossMargins": 0.77852, "ebitdaMargins": 0.49074, "operatingMargins": 0.40802, "financialCurrency": "USD", "symbol": "MRK", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1763773154, "regularMarketTime": 1763758802, "exchange": "NYQ", "messageBoardId": "finmb_288502", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": -252322200000, "postMarketChangePercent": 0.3784729, "postMarketPrice": 98.13, "postMarketChange": 0.36999512, "regularMarketChange": 2.79, "regularMarketDayRange": "95.36 - 100.27", "fullExchangeName": "NYSE", "averageDailyVolume3Month": 12592573, "fiftyTwoWeekLowChange": 24.450005, "fiftyTwoWeekLowChangePercent": 0.3335153, "fiftyTwoWeekRange": "73.31 - 105.07", "fiftyTwoWeekHighChange": -7.3099976, "fiftyTwoWeekHighChangePercent": -0.06957264, "fiftyTwoWeekChangePercent": -6.1190186, "dividendDate": 1759795200, "earningsTimestamp": 1761827400, "earningsTimestampStart": 1761827400, "earningsTimestampEnd": 1761827400, "earningsCallTimestampStart": 1770127200, "earningsCallTimestampEnd": 1770127200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 7.56, "epsForward": 9.4, "epsCurrentYear": 8.96748, "priceEpsCurrentYear": 10.901614, "fiftyDayAverageChange": 11.693001, "fiftyDayAverageChangePercent": 0.13585928, "twoHundredDayAverageChange": 13.740303, "twoHundredDayAverageChangePercent": 0.16353668, "regularMarketChangePercent": 2.93777, "regularMarketPrice": 97.76, "longName": "Merck & Co., Inc.", "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "shortName": "Merck & Company, Inc.", "displayName": "Merck &", "trailingPegRatio": 1.0003, "__fetch_time": "2025-11-22"}]